A session-level reporting standard is proposed based on total active human interpretation minutes per 1000 women screened, work shifted elsewhere in the pathway, and diagnostic outcomes, together with a matched-session design to measure these effects directly.
Abstract
Artificial intelligence triage can sharply reduce the number of human readings in breast cancer screening. Reading count, however, does not show how much radiologist time is saved or whether work shifts to arbitration, consensus, or other tasks. We propose a session-level reporting standard based on total active human interpretation minutes per 1000 women screened, work shifted elsewhere in the pathway, and diagnostic outcomes, together with a matched-session design to measure these effects directly.
Abstract Background Artificial intelligence(AI) is increasingly proposed as a triage tool in mammography screening to reduce double reading workload. However, its impact on cancer detection and screening performance remains uncertain. Within a project funded by the Italian Ministry of Health on the evaluation of AI in...
M. Riccardi, M. Nurchis, C. Savoia et al.· European Journal of Public H...· 0 citations
This article, from a Point/Counterpoint on implementation of artificial intelligence (AI) in breast imaging, argues that key issues must be addressed before wider adoption, including medicolegal ambiguities, impact on disparities, data drift, and scaling costs. More robust infrastructure and regulations will ultimate...
E. Langman, V. Loving· AJR. American journal of roe...· 0 citations
Simple Summary Artificial intelligence may help clinicians detect abnormalities on chest radiographs, but its usefulness depends on whether it identifies findings that clinicians miss. In 920 emergency department patients who underwent chest radiography and chest computed tomography within four hours, we compared a com...
When this Special Issue opened in January 2024, its premise was straightforward but ambitious: imaging had moved well beyond a gatekeeping role ahead of biopsy, and the structural, functional, and metabolic data extracted from ultrasound, CT, MRI, and PET were becoming primary evidence in their own right, with artifici...
Giovanni Sussan, F. Crimí· Tomography· 0 citations
Evidence from mammography screening, stroke and lung cancer pathways is examined alongside research on implementation, automation bias, deskilling, and accountability to argue that the clinical value of AI depends on whether it changes decisions, uses clinical time effectively, and improves patient care without creatin...
Artificial intelligence in mammography is a safe and effective tool with diagnostic performance comparable to or, in some settings, superior to traditional methods, when used as a complementary tool for radiologists.
Manuela Bernardes de Góes, Ana Carolina Marques Magalhães, Gabriela Bastos Mesquita et al.· Mastology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.